Navigation Links
Risk Of Death Increases With Sudden Withdrawal Of Medications

Journal of the American Heart Association reported that patients who had heart attack, and stopped taking antiplatelet drugs within 30 days of having //a drug-coated with stent have 7 times more risk of death than others.

"An alarming one in seven patients in our study stopped taking their antiplatelet medication within the first 30 days of receiving a drug-eluting stent (DES), even though they were prescribed the drugs at the time of hospital discharge and recommendations are to continue them for a minimum of three to six months after the procedure," said John A. Spertus, M.D., M.P.H., lead author of the study and director of cardiovascular education and outcomes research at the Mid America Heart Institute in Kansas City, Mo.

Researchers looked at the real-world use of DES in heart attack patients and a class of drugs called thienopyridines that work along with aspirin to help keep platelets in the blood from clumping and leading to the formation of blood clots. Thienopyridines include the drugs clopidogrel and ticlopidine. Blood clots can obstruct a coronary artery, causing a heart attack.

Several studies have confirmed the benefits of DES in preventing restenosis (reclosing of the artery that had been treated). However, with stents there is the potential problem of stent thrombosis (blood clots forming inside the stent), which can be associated with devastating consequences. Antiplatelet agents, including thienopyridines, reduce the likelihood of stent thrombosis. According to Spertus, no previous studies have defined the frequency and consequences of prematurely discontinuing thienopyridine therapy.

The risk of stent thrombosis with bare-metal stents (stents not coated with a drug) decreases rapidly after two to four weeks, and patients typically need thienopyridines for only about one month. In comparison, with drug-eluting stents the risk of stent thrombosis lasts for a longer period of time and patients with DES requir
'"/>




Page: 1 2 3

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death

Post Your Comments:
(Date:12/1/2009)...dy accepted for publication in The Endocrine Socie...sm ( JCEM ), youth with type 1 diabetes have now ...aving abnormal insulin resistance appears to negat...tion in this population. , Type 1 diabetes ofte...es have their insulin resistance measured routinel...
(Date:12/1/2009)...- Sentinelle Medical Inc., a leading manufacturer ...software, extends its line of award winning breast...h America (RSNA) annual meeting in Chicago, Nov. 3...the unique Vanguard(R) patient support design and ...,s line of breast coils are recognized for deliver...
(Date:12/1/2009)...z, a fourth-year medical student at Ross Universit...nal medicine to help fulfill an unmet need. , ...ecember 1, 2009 -- Having distinguished himself wi...tions, Craig Moskowitz--a fourth-year medical stud... could go into any area of medicine that he chose....
(Date:12/1/2009)...dan Fiddle Foundation, a national autism organizat... support programs and services for adolescents and...released a free informational brochure entitled &q...nize The Signs and Basic First Aid When You Do.&qu...) December 1, 2009 -- Statistics show that as many...
(Date:12/1/2009)...wswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)...at the 21st Annual Piper Jaffray Health Care Confe... Time will be webcast live at www.celltherapeutic...n Holmes 1 at the New York Palace Hotel, and will ...n. , , Piper Jaffray Health ...
Breaking Medicine News(10 mins):Health News:Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4
...ry issue of Archives of General Psychiatry, one of...specially physical signs, such as// fatigue and lo...rteries, which may reflect an early sign of corona...ery disease, which occurs when the vessels carryin...
...ine journal PLoS Biology concluded that the low le... in the central nervous system to// prematurely sh... identify a common molecular trigger for the effec...s. While scientists have long understood that...
...a from 55 developing countries has shown that, a ‘...e rest of society.// It was already well know...risen over several decades, but it was not clear w...ealth Organization HQ in Geneva brought together d...
...ment to gender equality, women are still underrepr...hile the impact of gender differences// continues ... in the Journal of Medical Ethics. The autho...ria and The Netherlands in 2003. Before rese...
...Australia is an ongoing problem according to Austr...// In the latest edition of the Medical Jou...r address some of the issues surrounding organ don...or rates, and the third the participation of priso...
...uccumb to bird flu, bringing the death toll from t...ssan el-Bushra, regional adviser for communicable ...ation said the girl was believed to have been infe... Bushra said she had started showing symptoms of t...
Other Medicine News:Health News:Symptoms of Depression Associated With Artery Diseases 2Health News:Environmental Toxicants Target Stem Cells 2Health News:Environmental Toxicants Target Stem Cells 3Health News:European Medical Research Still Ignoring Women 2Health News:The Search for Organ Donors 2
(Date:11/30/2009)...Newswire/ -- Microban International, Ltd., the glo...ction, is pleased to announce their exclusive Nort...gest U.S. manufacturer and distributor of ceramic ...g two new lines of ceramic tile with OutStand Tech...ng silver based technology, in order to create a l...
(Date:11/30/2009)...RNewswire-FirstCall/ -- Nektar Therapeutics (Nasda...ne Masuoka, M.D. to Senior Vice President and Chie...ly to Nektar,s President and Chief Executive Offic...ng leadership and highly effective clinical develo... advancing Nektar,s proprietary clinical pipeline,...
(Date:11/30/2009)... Breast-Specific Gamma Imaging (BSGI) significantl...h-risk lesions in patients with negative or indete...s of a multicenter study presented today at the an...America (RSNA). ,, In this retrospective study,...ng modality at four institutions and was compared ...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Quality of Medicines Advanced by Agreement Between USP Mexican Standards Body 55335 1Quality of Medicines Advanced by Agreement Between USP Mexican Standards Body 55335 2ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 1ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 2ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 3More Women Surviving After Early Breast Cancer 55327 1More Women Surviving After Early Breast Cancer 55327 2More Women Surviving After Early Breast Cancer 55327 3
...mory Imprint to Yield a Strong and ...g. 20 Intellect Neurosciences,Inc. (OTC Bulletin ...n,development of disease-modifying therapeutic age...s disease and related disorders, announced today,t... present new data,regarding the Company,s RECALL-V...
...r Coiling Since Groundbreaking 2002 ... 1 A new study reveals that,coiling, a minimally ..., is,successful in preventing recurrent or first-t...e aneurysms considered "untouchable" by the,tradit... findings since the,2002 release of the Internatio...
Other Medicine Technology:Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 2Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 3New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3
Optima III Noninsulated Babcock Grasper, with ratchet
Optima III Noninsulated Retraction Grasper, with ratchet
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Medicine Products: